@bot@lemmy.smeargle.fansMB to Hacker News@lemmy.smeargle.fans • 30 days agoTrial results for new lung cancer drug are 'off the charts'www.theguardian.comexternal-linkmessage-square3fedilinkarrow-up115file-textcross-posted to: technology@lemmit.onlinemedicine@mander.xyzupliftingnews@lemmit.onlineworldnews@lemmit.onlineupliftingnews@lemmit.onlineworld@lemmy.world
arrow-up115external-linkTrial results for new lung cancer drug are 'off the charts'www.theguardian.com@bot@lemmy.smeargle.fansMB to Hacker News@lemmy.smeargle.fans • 30 days agomessage-square3fedilinkfile-textcross-posted to: technology@lemmit.onlinemedicine@mander.xyzupliftingnews@lemmit.onlineworldnews@lemmit.onlineupliftingnews@lemmit.onlineworld@lemmy.world
minus-square@will_a113@lemmy.mllinkfedilink3•30 days agoNew drug: 60% survival rate with no disease progression. Current-best drug: 8% While technically it’s not “off the charts”, this is pretty damn impressive. I’ll allow the hyperbole.
New drug: 60% survival rate with no disease progression.
Current-best drug: 8%
While technically it’s not “off the charts”, this is pretty damn impressive. I’ll allow the hyperbole.